Skip to main content
Top

07-03-2018 | Kawasaki disease | Case report | Article

Kawasaki Disease in the neonate: case report and literature review

Journal: Pediatric Rheumatology

Authors: Fajer Altammar, Bianca Lang

Publisher: BioMed Central

Abstract

Background

Kawasaki Disease (KD), the leading cause of acquired heart disease in children in the developed world, is extremely rare in neonates. We present a case of incomplete KD in a neonate and a review of the literature on neonatal KD.

Case presentation

A previously healthy full term 15 day old Caucasian male with an unremarkable antenatal and perinatal history, presented on Day 2 of illness with fever, rash, irritability, and poor feeding. Examination revealed fever (39.6C), tachycardia, tachypnea, extreme irritability, and a generalized maculopapular rash, but was otherwise normal. His complete blood count, CRP and ESR were normal. Empiric intravenous antibiotics and acyclovir resulted in no improvement. On day 4, he had ongoing fever and developed recurrent apnea, required supplemental oxygen, and was transferred to the pediatric intensive care unit. On day 6, he developed bilateral non-purulent conjunctivitis, palmar erythema, bilateral non-pitting edema and erythema of his feet, and arthritis. His full septic work-up and viral studies were negative. On Day 7 he was treated with intravenous immunoglobulin, and over the next 48 h his symptoms including extremity edema resolved, he no longer required supplemental oxygen, and fever did not recur. On day 9 of illness he had marked thrombocytosis. Subsequently, he developed distal extremity desquamation. Repeated echocardiograms excluded the presence of coronary artery aneurysms (CAA).

Conclusions

We believe this to be a rare case of incomplete KD in a neonate, in which timely IVIG administration led to resolution of the acute illness and may have prevented CAA. A comprehensive English-language medical literature review of KD presenting in the neonatal period revealed only fifteen case reports. Cases often presented with incomplete KD, and a number had atypical laboratory features including a normal CRP in the acute phase, similar to what was seen in our patient. This case and our literature review should increase awareness that KD can rarely occur in neonates, often presenting atypically. Recognizing KD in a neonate enables appropriate treatment that can result in resolution of symptoms and may decrease the risk of cardiac complications.
Literature
1.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.CrossRefPubMed
2.
Furusho K, Nakano H, Shinomiya K. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984;2:1055–7.CrossRefPubMed
3.
Newburger JW, Takahashi M, Burns JC. Treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341–7.CrossRefPubMed
4.
Tsuchida S, Yamanaka T, Tsuchida R, Nakamura Y, Yashiro M, Yanagawa H. Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Paediatr. 1996;85(8):995–7.CrossRefPubMed
5.
Hangai M, Kubota Y, Kagawa J, Yashiro M, Uehara R, Nakamura Y, et al. Neonatal Kawasaki disease: case report and data from nationwide survey in Japan. Eur J Pediatr. 2014;173(11):1533–6.CrossRefPubMed
6.
Stanley TV, Grimwood K. Classical Kawasaki disease in a neonate. Arch Dis Child Fetal Neonatal Ed. 2002; https://​doi.​org/​10.​1136/​fn.​86.​2.​F135.
7.
Nakagawa N, Yoshida M, Narahara K, Kunitomi T. Kawasaki disease in an 8-day-old neonate. Pediatr Cardiol. 2009;30(4):527–9.CrossRefPubMed
8.
Thapa R, Pramanik S, Dhar S, Kundu R. Neonatal Kawasaki disease with multiple coronary aneurysms and thrombocytopenia. Pediatr Dermatol. 2007;24(6):662–3.CrossRefPubMed
9.
Bhatt M, Anil SR, Sivakumar K, Kumar K. Neonatal Kawasaki disease. Indian J Pediatr. 2004;71(4):353–4.CrossRefPubMed
10.
Karia VR, Hescock GC, Gedalia A, Ross-Ascuitto N. Successful emergent coronary thrombolysis in a neonate with Kawasaki's disease. Pediatr Cardiol. 2010;31(8):1239–42.CrossRefPubMed
11.
Mitchell S, Francis J, Burgner D. Kawasaki disease in the neonatal period. J Pediatr Infect Dis. 2011;6(4):265–7.CrossRef
12.
Nasir A, Al Tatari H, Hamdan MA. Very high serum ferritin levels in three newborns with Kawasaki-like illness. Paediatr Child Health. 2012;17(4):201–4.CrossRefPubMedPubMedCentral
13.
Bolz D, Arbenz U, Fanconi S, Bauersfeld U. Myocarditis and coronary dilatation in the 1st week of life: neonatal incomplete Kawasaki disease? Eur J Pediatr. 1998;157(7):589–91.CrossRefPubMed
14.
Parashar R, Lysecki PJ, Mondal T. Diffuse coronary artery dilatation in a neonate: a case report. J Neonatal Perinatal Med. 2013;6(3):263–6.PubMed
15.
Krapf R, Zimmerman A, Stocker F. Lethal vasculitic of coronary arteries in a neonate and two infants: possible neonatal variant of the MLNS/IPN complex? Helv Paediatr Acta. 1981;36:589–98.PubMed
16.
Burns AC, Wiggins JW, Toews WH, Newburger JW, Leung DYM, Wilson H, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr. 1986;109:759–63.CrossRefPubMed
17.
Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr. 1995;126:524–9.CrossRefPubMed
18.
Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants – do we need criteria? West J Med. 1995;162:322–7.PubMedPubMedCentral
19.
Lee KY, Hong JH, Han JW, Lee JS, Lee JS, Burgner D. Features of Kawasaki disease at the extremes of age. J Paediatr Child Heath. 2006;42(7–8):423–7.CrossRef
20.
Manlhiot C, Yeung R, Clarizi N, Chaha N, McCrindle B. Kawasaki disease at the extremes of the age spectrum. Pediatrics. 2009;124(3):E410–5.CrossRefPubMed
21.
Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD, et al. Pediatric heart network investigators. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007; https://​doi.​org/​10.​1542/​peds.​2007-0815.​
22.
Koyanagi H, Yanagawa H, Nakamura Y, Yashiro M. Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan. Acta Paediatr. 1997;86:613–7.CrossRefPubMed
23.
Chang FY, Hwang B, Chen SJ. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J. 2006;25(3):241–4.CrossRefPubMed
24.
Singh S, Agarwal S, Bhattad S, Gupta A, Suri D, Rawat A, et al. Kawasaki disease in infants below 6 months: a clinical conundrum? Int J Rheum Dis. 2016;19(9):924–8.CrossRefPubMed
25.
Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr. 2017; https://​doi.​org/​10.​1016/​j.​jpeds.​2017.​03.​025.​
26.
Roberts FB, Fetterman GH. Polyarteritis Nodosa in infancy. J Pediatr. 1963;63(4):519–29.CrossRefPubMed
27.
Landing BH, Larson EJ. Are infantile Periarteritis Nodosa with coronary artery involvement and fatal Mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics. 1977;59(5):651–62.PubMed
28.
Burns JC. History of the worldwide emergence of Kawasaki disease. Int J Rheum Dis. 2018;21:13–5.CrossRefPubMed
29.
Yoshino A, Tanaka R, Takano T, Oishi T. Afebrile Kawasaki disease with coronary artery dilatation. Pediatr Int. 2017;59:375–7.CrossRefPubMed
30.
Pinches H, Dobbins K, Cantrell S, May J, Lopreiato J. Asymptomatic Kawasaki disease in a 3-month-old infant. Pediatrics. 2016:e20153936. https://​doi.​org/​10.​1542/​peds.​2015-3936.
31.
Pannaraj PS, Turner CL, Bastian JF, Burns JC. Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J. 2004;23(8):789–91.CrossRefPubMed